Reports for TEVA-MONTELUKAST
Brand name
TEVA-MONTELUKAST
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02355515 |
Ingredients
MONTELUKAST |
Ingredient Strength
5 MG |
ATC Code
R03DC |
ATC Descriptor
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-MONTELUKAST | 30 | Resolved | 2019-09-05 | 2019-09-27 | 93134 |
| TEVA-MONTELUKAST | 30 PP | Resolved | 2020-03-06 | 2020-05-14 | 107992 |
| TEVA-MONTELUKAST | 30 | Resolved | 2022-06-30 | 2022-10-18 | 163951 |
Showing 1 to 3 of 3
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0